261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
TED · 482465-2026Award noticeawardedNo deadline given
Value
Estimated€71,125 · 71,125 EUR
Awarded€71,125 · 71,125 EUR
WinnerCICLUM FARMA UNIPESSOAL, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 14 | — | 2026-07-07 |
| GILEAD SCIENCES, LDA | 10 | — | 2026-05-27 |
| NOVARTIS FARMA - PROD.FARM SA | 9 | — | 2026-06-30 |
| AMGEN BIOFARMACEUTICA, LDA | 8 | €396,644 | 2026-06-24 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 7 | €1,569,649 | 2026-07-07 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33651500 Medical equipment & pharmaceuticalsDescription
C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-13 | 261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab ) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-05-12 | 261G000513 - C.Central Medicamentos 2026 - 2026/0234 - UPADACITINIB | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-05-12 | 261G000583 - C.Central Medicamentos 2026 - 2026/0263 - BEDAQUILINA | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-05-12 | 261G000609 - C.Central Medicamentos 2026 - 2026/0274 | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-05-05 | 261G000570 - C.Central Medicamentos 2026 - 2026/0250 | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-06-02 | 261G000649 - C.Central Medicamentos 2026 - 2026/0297 - METRELEPTINA | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |